FDA Issues Warning Letter to Quality CDMO
September 18, 2024
September 18, 2024
WASHINGTON, Sept. 18 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Quality CDMO, Inc.:
* * *
To: Anin Shakiba, President, Quality CDMO, Inc., 5000 South Freeway, Suite 106, Fort Worth, TX 76115, United States, a.shakiba@qcdmo.com
Dear Mr. Shakiba:
The U.S. Food and Drug Administration inspected your drug manufacturing facility, Quality CDMO, Inc. FEI 3017569510, at 5000 S . . .
* * *
To: Anin Shakiba, President, Quality CDMO, Inc., 5000 South Freeway, Suite 106, Fort Worth, TX 76115, United States, a.shakiba@qcdmo.com
Dear Mr. Shakiba:
The U.S. Food and Drug Administration inspected your drug manufacturing facility, Quality CDMO, Inc. FEI 3017569510, at 5000 S . . .